Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands

Table 2

			Lipid percent (%)
CTT2-SL liposome
DSPE-mPEG2000	3.2 mg/ml	1.2 mM	5.5%
HSPC	9.6 mg/ml	12.2 mM	56.2%
Cholesterol	3.2 mg/ml	8.2 mM	38.1%
CTT2-PEG-lipid	0.2 mg/ml	0.04 mM	0.2%
Total lipids	16.2 mg/ml	21.6 mM	100.00%
Caelyx
DSPE-mPEG2000	3.2 mg/ml	1.2 mM	5.5%
HSPC	9.6 mg/ml	12.2 mM	56.3%
Cholesterol	3.2 mg/ml	8.2 mM	38.2%
Total lipids	16.0 mg/ml	21.6 mM	100.0%